John Piscitelli
Principal Scientist Takeda Pharmaceutical
Seminars
Wednesday 29th April 2026
TAK-500 ADC Analytical Control Strategy (ACS)
4:00 pm
- Discussion of complex Analytical Control strategy (ACS) and Critical Quality Attributes (CQA) used to evaluate Takeda ADC in early phase clinical study
- Review of analytical challenges and troubleshooting
